Colavita Laura, Catalano Natalia, Sposito Giovanna, Loddo Saverio, Galletti Bruno, Salpietro Carmelo, Galletti Francesco, Cuppari Caterina
Department of Pediatrics, Hospital "Umberto I" of Siracusa, Siracusa, Italy.
Department of Otolaryngology, University Hospital of Messina, Messina, Italy.
Int J Mol Cell Med. 2017 Summer;6(3):174-182. doi: 10.22088/acadpub.BUMS.6.3.174. Epub 2017 Sep 26.
Local Allergic Rhinitis (LAR) is an emerging disease. However, its incidence in the pediatric popolution has not yet been studied. The gold standard for the diagnosis is the nasal provocation test that is not everywhere avalaible and difficult to apply in children. The aim of our study was to evaluate the nasal lavage fluid IgE as a biomarker of LAR in children. 54 pediatric patients [IQR 4.0-12.0 years] were divided into 3 groups: study group (26 children with rhinitis symptoms and without evidence of systemic atopy); allergic rhinitis (AR) group (15 children) and 13 healty controls (HC). Every child was subjected to nasal lavage using 2 ml/nostril of physiologic saline solution, that was therefore analyzed by ImmunoCAP to obtain the IgE concentration. Rhinofibroscopy and nasal cytology were performed. Our data showed the presence of higher value of nasal lavage fluid IgE (average of 6.005 UI/ml; range: 4.47-7.74 UI/ml) in 16 out of 26 patients of the study group who therefore may be classified as affected by LAR. We observed a statistically significant difference (P< 0.0001) between NAR/HC group and LAR group, identifying a cut-off of 3.85 UI/ml. Finally, we found a better response to previous AR therapy in the LAR group than in the NAR group. Our data showed the high incidence of LAR in pediatric patients previously classified as NAR. The measurment of IgE in nasal lavage fluid may be considered an easy and rapid method for the diagnosis of LAR in children. Besides, our data add confirmatory evidence about the good response of LAR children to the classic AR therapy.
局部变应性鼻炎(LAR)是一种新出现的疾病。然而,其在儿童群体中的发病率尚未得到研究。诊断的金标准是鼻激发试验,但该试验并非在所有地方都可进行,且难以应用于儿童。我们研究的目的是评估鼻灌洗液IgE作为儿童LAR生物标志物的情况。54例儿科患者[四分位间距4.0 - 12.0岁]被分为3组:研究组(26例有鼻炎症状且无全身特应性证据的儿童);变应性鼻炎(AR)组(15例儿童)和13例健康对照(HC)。每个儿童使用每侧鼻孔2毫升生理盐水进行鼻灌洗,然后通过免疫化学发光法(ImmunoCAP)分析以获得IgE浓度。进行了鼻纤维镜检查和鼻细胞学检查。我们的数据显示,研究组26例患者中有16例鼻灌洗液IgE值较高(平均6.005 UI/ml;范围:4.47 - 7.74 UI/ml),因此这些患者可能被归类为患有LAR。我们观察到NAR/HC组和LAR组之间存在统计学显著差异(P < 0.0001),确定临界值为3.85 UI/ml。最后,我们发现LAR组对先前AR治疗的反应比NAR组更好。我们的数据显示,先前被归类为NAR的儿科患者中LAR发病率较高。鼻灌洗液中IgE的测量可被认为是诊断儿童LAR的一种简便快速的方法。此外,我们的数据增加了关于LAR儿童对经典AR治疗反应良好的确证证据。